Yucel KB, Aydos U, Sutcuoglu O, Kilic ACK, et al. Visceral obesity and sarcopenia as predictors of efficacy and hematological toxicity in patients with metastatic breast cancer treated with CDK 4/6 inhibitors. Cancer Chemother Pharmacol 2024 Mar 4. doi: 10.1007/s00280-024-04641.
PMID: 38436714